Naseem Amin - 17 May 2024 Form 4 Insider Report for AVADEL PHARMACEUTICALS PLC (AVDL)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AVDL	Stock Option (Right to Buy)	Award	$0	+49,500		$0.000000	49,500	17 May 2024	Ordinary Shares	49,500	$15.94	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The options become exercisable in three equal annual installments on each of the first three anniversaries following the 5/17/2024 grant date, subject to the Reporting Person's continued service at each such vesting date.